CPX-351 exploits the gut microbiota to promote mucosal barrier function, colonization resistance, and immune homeostasis

2.

Lancet

JE

,

Uy

GL

,

Cortes

JE

, et al.

CPX-351 (cytarabine and daunorubicin) liposome for injection versus conventional cytarabine plus daunorubicin in older patients with newly diagnosed secondary acute myeloid leukemia

.

J Clin Oncol

.

2018

;

36

(

26

):

2684

-

2692

.

3.

Tzogani

K

,

Penttila

K

,

Lapvetelainen

T

, et al.

EMA review of daunorubicin and cytarabine encapsulated in liposomes (Vyxeos, CPX-351) for the treatment of adults with newly diagnosed, therapy-related acute myeloid leukemia or acute myeloid leukemia with myelodysplasia-related changes

.

Oncologist

.

2020

;

25

(

9

):

e1414

-

e1420

.

4.

Przespolewski

A

,

Goldberg

AD

,

Talati

C

, et al.

Safety and efficacy of CPX-351 in younger patients (<60 years old) with secondary acute myeloid leukemia

.

Blood

.

2023

;

141

(

12

):

1489

-

1493

.

5.

Chiche

E

,

Rahme

R

,

Bertoli

S

, et al.

Real-life experience with CPX-351 and impact on the outcome of high-risk AML patients: a multicentric French cohort

.

Blood Adv

.

2021

;

5

(

1

):

176

-

184

.

6.

Guolo

F

,

Fianchi

L

,

Minetto

P

, et al.

CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation: results of the Italian compassionate use program

.

Blood Cancer J

.

2020

;

10

(

10

):

96

.

7.

Ting

NL

,

Lau

HC

,

Yu

J

.

Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes

.

Gut

.

2022

;

71

(

7

):

1412

-

1425

.

8.

Alexander

JL

,

Wilson

ID

,

Teare

J

,

Marchesi

JR

,

Nicholson

JK

,

Kinross

JM

.

Gut microbiota modulation of chemotherapy efficacy and toxicity

.

Nat Rev Gastroenterol Hepatol

.

2017

;

14

(

6

):

356

-

365

.

9.

Cheng

WY

,

Wu

CY

,

Yu

J

.

The role of gut microbiota in cancer treatment: friend or foe?

.

Gut

.

2020

;

69

(

10

):

1867

-

1876

.

10.

Panebianco

C

,

Andriulli

A

,

Pazienza

V

.

Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies

.

Microbiome

.

2018

;

6

(

1

):

92

.

11.

Rashidi

A

,

Ebadi

M

,

Rehman

TU

, et al.

Loss of microbiota-derived protective metabolites after neutropenic fever

.

Sci Rep

.

2022

;

12

(

1

):

6244

.

12.

Galloway-Pena

JR

,

Shi

Y

,

Peterson

CB

, et al.

Gut microbiome signatures are predictive of infectious risk following induction therapy for acute myeloid leukemia

.

Clin Infect Dis

.

2020

;

71

(

1

):

63

-

71

.

13.

Rashidi

A

,

Ebadi

M

,

Rehman

TU

, et al.

Lasting shift in the gut microbiota in patients with acute myeloid leukemia

.

Blood Adv

.

2022

;

6

(

11

):

3451

-

3457

.

14.

Rashidi

A

,

Kaiser

T

,

Shields-Cutler

R

, et al.

Dysbiosis patterns during re-induction/salvage versus induction chemotherapy for acute leukemia

.

Sci Rep

.

2019

;

9

(

1

):

6083

.

15.

Rashidi

A

,

Kaiser

T

,

Graiziger

C

, et al.

Specific gut microbiota changes heralding bloodstream infection and neutropenic fever during intensive chemotherapy

.

Leukemia

.

2020

;

34

(

1

):

312

-

316

.

16.

Khuat

LT

,

Dave

M

,

Murphy

WJ

.

The emerging roles of the gut microbiome in allogeneic hematopoietic stem cell transplantation

.

Gut Microbes

.

2021

;

13

(

1

):

1966262

.

17.

Zeng

X

,

Li

X

,

Li

X

, et al.

Fecal microbiota transplantation from young mice rejuvenates aged hematopoietic stem cells by suppressing inflammation

.

Blood

.

2023

;

141

(

14

):

1691

-

1707

.

18.

Peled

JU

,

Gomes

ALC

,

Devlin

SM

, et al.

Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation

.

N Engl J Med

.

2020

;

382

(

9

):

822

-

834

.

19.

Vincelette

ND

,

Ding

H

,

Huehls

AM

, et al.

Effect of CHK1 inhibition on CPX-351 cytotoxicity in vitro and ex vivo

.

Sci Rep

.

2019

;

9

(

1

):

3617

.

20.

Renga

G

,

Nunzi

E

,

Pariano

M

, et al.

Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite

.

J Immunother Cancer

.

2022

;

10

(

3

):

e003725

.

21.

Hueso

T

,

Ekpe

K

,

Mayeur

C

, et al.

Impact and consequences of intensive chemotherapy on intestinal barrier and microbiota in acute myeloid leukemia: the role of mucosal strengthening

.

Gut Microbes

.

2020

;

12

(

1

):

1800897

.

22.

Wunderlich

M

,

Mizukawa

B

,

Chou

FS

, et al.

AML cells are differentially sensitive to chemotherapy treatment in a human xenograft model

.

Blood

.

2013

;

121

(

12

):

e90

-

97

.

23.

Claassen

V

. Neglected factors in pharmacology and neuroscience research : biopharmaceutics, animal characteristics, maintenance, testing conditions.

Elsevier

;

1994

.

24.

Rothhammer

V

,

Quintana

FJ

.

The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and disease

.

Nat Rev Immunol

.

2019

;

19

(

3

):

184

-

197

.

25.

Stockinger

B

,

Shah

K

,

Wincent

E

.

AHR in the intestinal microenvironment: safeguarding barrier function

.

Nat Rev Gastroenterol Hepatol

.

2021

;

18

(

8

):

559

-

570

.

26.

Yu

M

,

Wang

Q

,

Ma

Y

, et al.

Aryl hydrocarbon receptor activation modulates intestinal epithelial barrier function by maintaining tight junction integrity

.

Int J Biol Sci

.

2018

;

14

(

1

):

69

-

77

.

27.

Sonnenberg

GF

,

Fouser

LA

,

Artis

D

.

Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22

.

Nat Immunol

.

2011

;

12

(

5

):

383

-

390

.

28.

Nguyen

HD

,

Aljamaei

HM

,

Stadnyk

AW

.

The production and function of endogenous interleukin-10 in intestinal epithelial cells and gut homeostasis

.

Cell Mol Gastroenterol Hepatol

.

2021

;

12

(

4

):

1343

-

1352

.

29.

Hasani

M

,

Sani

NA

,

Khodabakhshi

B

,

Arabi

MS

,

Mohammadi

S

,

Yazdani

Y

.

Encapsulation of Leflunomide (LFD) in a novel niosomal formulation facilitated its delivery to THP-1 monocytic cells and enhanced Aryl hydrocarbon receptor (AhR) nuclear translocation and activation

.

Daru

.

2019

;

27

(

2

):

635

-

644

.

30.

Dicko

A

,

Kwak

S

,

Frazier

AA

,

Mayer

LD

,

Liboiron

BD

.

Biophysical characterization of a liposomal formulation of cytarabine and daunorubicin

.

Int J Pharm

.

2010

;

391

(

1-2

):

248

-

259

.

31.

Puccetti

M

,

Pariano

M

,

Borghi

M

, et al.

Enteric formulated indole-3-carboxaldehyde targets the aryl hydrocarbon receptor for protection in a murine model of metabolic syndrome

.

Int J Pharm

.

2021

;

602

:

120610

.

32.

Dong

F

,

Perdew

GH

.

The aryl hydrocarbon receptor as a mediator of host-microbiota interplay

.

Gut Microbes

.

2020

;

12

(

1

):

1859812

.

33.

Mar

JS

,

Ota

N

,

Pokorzynski

ND

, et al.

IL-22 alters gut microbiota composition and function to increase aryl hydrocarbon receptor activity in mice and humans

.

Microbiome

.

2023

;

11

(

1

):

47

.

34.

Sturgill

G

,

Rather

PN

.

Evidence that putrescine acts as an extracellular signal required for swarming in Proteus mirabilis

.

Mol Microbiol

.

2004

;

51

(

2

):

437

-

446

.

35.

Garai

P

,

Chandra

K

,

Chakravortty

D

.

Bacterial peptide transporters: messengers of nutrition to virulence

.

Virulence

.

2017

;

8

(

3

):

297

-

309

.

36.

Coburn

B

,

Sekirov

I

,

Finlay

BB

.

Type III secretion systems and disease

.

Clin Microbiol Rev

.

2007

;

20

(

4

):

535

-

549

.

37.

Flemming

HC

,

Wingender

J

.

The biofilm matrix

.

Nat Rev Microbiol

.

2010

;

8

(

9

):

623

-

633

.

38.

Menezes-Garcia

Z

,

Kumar

A

,

Zhu

W

,

Winter

SE

,

Sperandio

V

.

l-Arginine sensing regulates virulence gene expression and disease progression in enteric pathogens

.

Proc Natl Acad Sci U S A

.

2020

;

117

(

22

):

12387

-

12393

.

39.

Rowley

CA

,

Kendall

MM

.

To B12 or not to B12: Five questions on the role of cobalamin in host-microbial interactions

.

PLoS Pathog

.

2019

;

15

(

1

):

e1007479

.

40.

Pereira

CS

,

Thompson

JA

,

Xavier

KB

.

AI-2-mediated signalling in bacteria

.

FEMS Microbiol Rev

.

2013

;

37

(

2

):

156

-

181

.

41.

Feehily

C

,

Karatzas

KA

.

Role of glutamate metabolism in bacterial responses towards acid and other stresses

.

J Appl Microbiol

.

2013

;

114

(

1

):

11

-

24

.

42.

Saier

MH

.

The bacterial phosphotransferase system: new frontiers 50 years after its discovery

.

J Mol Microbiol Biotechnol

.

2015

;

25

(

2-3

):

73

-

78

.

43.

Neganova

M

,

Semakov

A

,

Aleksandrova

Y

, et al.

N-alkylation of anthracycline antibiotics by natural sesquiterpene lactones as a way to obtain antitumor agents with reduced side effects

.

Biomedicines

.

2021

;

9

(

5

):

547

.

44.

Choi

K

,

Jeon

BS

,

Kim

BC

,

Oh

MK

,

Um

Y

,

Sang

BI

.

In situ biphasic extractive fermentation for hexanoic acid production from sucrose by Megasphaera elsdenii NCIMB 702410

.

Appl Biochem Biotechnol

.

2013

;

171

(

5

):

1094

-

1107

.

45.

Rios-Covian

D

,

Gonzalez

S

,

Nogacka

AM

, et al.

An overview on fecal branched short-chain fatty acids along human life and as related with body mass index: associated dietary and anthropometric factors

.

Front Microbiol

.

2020

;

11

:

973

.

46.

Zelante

T

,

Iannitti

RG

,

Cunha

C

, et al.

Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22

.

Immunity

.

2013

;

39

(

2

):

372

-

385

.

47.

Jiang

X

,

Lu

N

,

Zhao

H

,

Yuan

H

,

Xia

D

,

Lei

H

.

The microbiome-metabolome response in the colon of piglets under the status of weaning stress

.

Front Microbiol

.

2020

;

11

:

2055

.

48.

Abdugheni

R

,

Wang

W-Z

,

Wang

Y-J

, et al.

Metabolite profiling of human-originated Lachnospiraceae at the strain level

.

Imeta

.

2022

;

1

(

4

):

e58

.

49.

Sasaki-Imamura

T

,

Yoshida

Y

,

Suwabe

K

,

Yoshimura

F

,

Kato

H

.

Molecular basis of indole production catalyzed by tryptophanase in the genus Prevotella

.

FEMS Microbiol Lett

.

2011

;

322

(

1

):

51

-

59

.

50.

van de Wouw

M

,

Walsh

CJ

,

Vigano

GMD

, et al.

Kefir ameliorates specific microbiota-gut-brain axis impairments in a mouse model relevant to autism spectrum disorder

.

Brain Behav Immun

.

2021

;

97

:

119

-

134

.

51.

Takahashi

M

,

Inoue

S

,

Hayama

K

,

Ninomiya

K

,

Abe

S

.

[Inhibition of Candida mycelia growth by a medium chain fatty acids, capric acid in vitro and its therapeutic efficacy in murine oral candidiasis]

.

Med Mycol J

.

2012

;

53

(

4

):

255

-

261

.

52.

Rizzatti

G

,

Lopetuso

LR

,

Gibiino

G

,

Binda

C

,

Gasbarrini

A

.

Proteobacteria: a common factor in human diseases

.

Biomed Res Int

.

2017

;

2017

:

9351507

.

53.

Rashidi

A

,

Weisdorf

DJ

.

Microbiota-based approaches to mitigate infectious complications of intensive chemotherapy in patients with acute leukemia

.

Transl Res

.

2020

;

220

:

167

-

181

.

54.

Shao

J

,

Li

Z

,

Gao

Y

, et al.

Construction of a "bacteria-metabolites" co-expression network to clarify the anti-ulcerative colitis effect of flavonoids of sophora flavescens aiton by regulating the "host-microbe" interaction

.

Front Pharmacol

.

2021

;

12

:

710052

.

55.

Shi

Y

,

Zou

Y

,

Xiong

Y

, et al.

Host Gasdermin D restrains systemic endotoxemia by capturing Proteobacteria in the colon of high-fat diet-feeding mice

.

Gut Microbes

.

2021

;

13

(

1

):

1946369

.

56.

Figliuolo

VR

,

Dos Santos

LM

,

Abalo

A

, et al.

Sulfate-reducing bacteria stimulate gut immune responses and contribute to inflammation in experimental colitis

.

Life Sci

.

2017

;

189

:

29

-

38

.

57.

Sarkar

A

,

Mandal

S

.

Bifidobacteria-Insight into clinical outcomes and mechanisms of its probiotic action

.

Microbiol Res

.

2016

;

192

:

159

-

171

.

58.

Precup

G

,

Vodnar

DC

.

Gut Prevotella as a possible biomarker of diet and its eubiotic versus dysbiotic roles: a comprehensive literature review

.

Br J Nutr

.

2019

;

122

(

2

):

131

-

140

.

59.

Mazmanian

SK

,

Round

JL

,

Kasper

DL

.

A microbial symbiosis factor prevents intestinal inflammatory disease

.

Nature

.

2008

;

453

(

7195

):

620

-

625

.

60.

Zgur-Bertok

D

.

DNA damage repair and bacterial pathogens

.

PLoS Pathog

.

2013

;

9

(

11

):

e1003711

.

61.

Lee

SI

,

Kang

KS

.

Function of capric acid in cyclophosphamide-induced intestinal inflammation, oxidative stress, and barrier function in pigs

.

Sci Rep

.

2017

;

7

(

1

):

16530

.

62.

Hanczakowska

E

,

Szewczyk

A

,

Okoń

K

.

Effects of dietary caprylic and capric acids on piglet performance and mucosal epithelium structure of the ileum

.

J Anim Feed Sci

.

2011

;

20

(

4

):

556

-

565

.

63.

Zelante

T

,

Puccetti

M

,

Giovagnoli

S

,

Romani

L

.

Regulation of host physiology and immunity by microbial indole-3-aldehyde

.

Curr Opin Immunol

.

2021

;

70

:

27

-

32

.

64.

Machate

DJ

,

Figueiredo

PS

,

Marcelino

G

, et al.

Fatty acid diets: regulation of gut microbiota composition and obesity and its related metabolic dysbiosis

.

Int J Mol Sci

.

2020

;

21

(

11

):

4093

.

65.

Desbois

AP

.

Potential applications of antimicrobial fatty acids in medicine, agriculture and other industries

.

Recent Pat Antiinfect Drug Discov

.

2012

;

7

(

2

):

111

-

122

.

66.

Weber

D

,

Oefner

PJ

,

Hiergeist

A

, et al.

Low urinary indoxyl sulfate levels early after transplantation reflect a disrupted microbiome and are associated with poor outcome

.

Blood

.

2015

;

126

(

14

):

1723

-

1728

.

67.

Wanten

GJ

,

Janssen

FP

,

Naber

AH

.

Saturated triglycerides and fatty acids activate neutrophils depending on carbon chain-length

.

Eur J Clin Invest

.

2002

;

32

(

4

):

285

-

289

.

68.

Schwab

L

,

Goroncy

L

,

Palaniyandi

S

, et al.

Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage

.

Nat Med

.

2014

;

20

(

6

):

648

-

654

.

69.

Russo

E

,

Cinci

L

,

Di Gloria

L

, et al.

Crohn's disease recurrence updates: first surgery vs. surgical relapse patients display different profiles of ileal microbiota and systemic microbial-associated inflammatory factors

.

Front Immunol

.

2022

;

13

:

886468

.

70.

Kaczmarek

A

,

Brinkman

BM

,

Heyndrickx

L

,

Vandenabeele

P

,

Krysko

DV

.

Severity of doxorubicin-induced small intestinal mucositis is regulated by the TLR-2 and TLR-9 pathways

.

J Pathol

.

2012

;

226

(

4

):

598

-

608

.

71.

van Vliet

MJ

,

Tissing

WJ

,

Dun

CA

, et al.

Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut

.

Clin Infect Dis

.

2009

;

49

(

2

):

262

-

270

.

72.

Zahednezhad

F

,

Saadat

M

,

Valizadeh

H

,

Zakeri-Milani

P

,

Baradaran

B

.

Liposome and immune system interplay: challenges and potentials

.

J Control Release

.

2019

;

305

:

194

-

209

.

73.

Cui

X

,

Wang

X

,

Chang

X

, et al.

A new capacity of gut microbiota: fermentation of engineered inorganic carbon nanomaterials into endogenous organic metabolites

.

Proc Natl Acad Sci U S A

.

2023

;

120

(

20

):

e2218739120

.

74.

Ji

J

,

Qu

H

.

Cross-regulatory circuit between AHR and microbiota

.

Curr Drug Metab

.

2019

;

20

(

1

):

4

-

8

.

75.

Zenewicz

LA

,

Yin

X

,

Wang

G

, et al.

IL-22 deficiency alters colonic microbiota to be transmissible and colitogenic

.

J Immunol

.

2013

;

190

(

10

):

5306

-

5312

.

76.

Lewis

RE

,

Chamilos

G

,

Prince

RA

,

Kontoyiannis

DP

.

Pretreatment with empty liposomes attenuates the immunopathology of invasive pulmonary aspergillosis in corticosteroid-immunosuppressed mice

.

Antimicrob Agents Chemother

.

2007

;

51

(

3

):

1078

-

1081

.

77.

Wang

Q

,

Tardi

P

,

Sadowski

N

,

Xie

S

,

Heller

D

,

Mayer

L

.

Pharmacokinetics, drug metabolism, and tissue distribution of CPX-351 in animals

.

Nanomedicine

.

2020

;

30

:

102275

.

78.

Mayer

LD

,

Tardi

P

,

Louie

AC

.

CPX-351: a nanoscale liposomal co-formulation of daunorubicin and cytarabine with unique biodistribution and tumor cell uptake properties

.

Int J Nanomedicine

.

2019

;

14

:

3819

-

3830

.

79.

Varasteh

S

,

Fink-Gremmels

J

,

Garssen

J

,

Braber

S

.

alpha-Lipoic acid prevents the intestinal epithelial monolayer damage under heat stress conditions: model experiments in Caco-2 cells

.

Eur J Nutr

.

2018

;

57

(

4

):

1577

-

1589

.

80.

Dietrich

C

.

Antioxidant functions of the aryl hydrocarbon receptor

.

Stem Cells Int

.

2016

;

2016

:

7943495

.

81.

Yen

HC

,

Oberley

TD

,

Gairola

CG

,

Szweda

LI

,

St Clair

DK

.

Manganese superoxide dismutase protects mitochondrial complex I against adriamycin-induced cardiomyopathy in transgenic mice

.

Arch Biochem Biophys

.

1999

;

362

(

1

):

59

-

66

.

82.

Lin

TL

,

Newell

LF

,

Stuart

RK

, et al.

A phase 2 study to assess the pharmacokinetics and pharmacodynamics of CPX-351 and its effects on cardiac repolarization in patients with acute leukemias

.

Cancer Chemother Pharmacol

.

2019

;

84

(

1

):

163

-

173

.

83.

Ziegler

M

,

Han

JH

,

Landsburg

D

, et al.

Impact of levofloxacin for the prophylaxis of bloodstream infection on the gut microbiome in patients with hematologic malignancy

.

Open Forum Infect Dis

.

2019

;

6

(

7

):

ofz252

.